The trajectory of Viagra, formerly marketed by copyright, presents a complex case study for backers considering the healthcare arena . Although its initial success and creation of billions in earnings , the exclusivity end has opened the floodgates for generic medications, significantly eroding profit opportunities. This change raises doubts about